|
|
Volumn 41, Issue 11, 2005, Pages 609-610
|
|
Case report: Clonidine withdrawal after atypically high-dose maintenance treatment [2]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLONIDINE;
METHYLPHENIDATE;
RISPERIDONE;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
ADOLESCENT;
ATTENTION DEFICIT DISORDER;
BEHAVIOR DISORDER;
CARDIOVASCULAR DISEASE;
CASE REPORT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIZZINESS;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG CONTRAINDICATION;
DRUG FATALITY;
DRUG MEGADOSE;
DRUG MONITORING;
DRUG SAFETY;
DRUG WITHDRAWAL;
ELECTROCARDIOGRAM;
FATIGUE;
HEART VENTRICLE TACHYCARDIA;
HUMAN;
HYPERTENSION;
HYPOTENSION;
LETTER;
LOW DRUG DOSE;
MALE;
MAXIMUM PERMISSIBLE DOSE;
OPPOSITIONAL DEFIANT DISORDER;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
SYMPATHETIC BLOCKING;
SYMPATHETIC TONE;
SYNCOPE;
TREATMENT DURATION;
AUSTRALIA;
WITHDRAWAL SYNDROME;
ADOLESCENT;
ADRENERGIC ALPHA-AGONISTS;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CLONIDINE;
HUMANS;
MALE;
SUBSTANCE WITHDRAWAL SYNDROME;
WESTERN AUSTRALIA;
|
|
EID: 33644837152
PISSN: 10344810
EISSN: 14401754
Source Type: Journal
DOI: 10.1111/j.1440-1754.2005.00733_1.x Document Type: Letter |
|
Times cited : (6)
|
|
References (8)
|
